Morningstar | SMIN Updated Forecasts and Estimates from 10 Jul 2019
Our key takeaways from Smiths Group's first-half results are that broadly, the businesses are tracking in line with expectations, at 2% revenue growth with some margin softness from temporary regulatory issues. Medical and detection's growth this year will be back-end loaded as expected. Management's guidance is for at least 2% underlying revenue growth. We are sticking to our 4% growth forecast. However, we suspect greater margin pressure on both of those businesses than we previously thought. All in, we still expect the company to meet our modest forecast of a 10-basis-point margin expansion to 17% but think it is unlikely to surprise on the upside. We continue to believe the shares are attractively valued, and while Smiths is a conglomerate, it is in possession of high-quality niche businesses that produce high margins and have low capital intensity. We are maintaining our narrow moat rating and GBX 1,810 and $23.20 fair value estimates.The company announced plans to separately list the medical division in the United Kingdom next calendar year, following its earlier announcement to separate the business. There are obvious incentives to improve the division's growth and margin before that time. However, the separate listing does not change our valuation.
While we expect group-level stable margins, in the detection division, we think equipment pricing pressure to secure long-term aftermarket might be holding down margin expansion despite high software content, and in medical management suggested that there were operational inefficiencies that new medical CEO would need to address. However, the group's largest profit contributor remains John Crane, the mechanical seal business, which is benefiting from late-cycle investments from downstream energy customers. Margins at John Crane expanded 40 basis points for the year. We expect second-half volume growth in detection and medical to lift second-half margins, giving us confidence in our full-year forecast.
Smiths Group is a global technology company. Co. is organized into five divisions: John Crane, which provides mechanical seals, seal support systems, engineered bearings and power transmission couplings; Smiths Medical, which provides infusion systems and vascular access products; Smiths Detection, which provides sensors and systems that detect and identify explosives narcotics, weapons, chemical agents, biohazards and contraband; Smiths Interconnect, which provides electronic and radio frequency board-level and waveguide devices; and Flex-Tek, which provides engineered components flexible hosing and tubing that heat and move fluids and gases.
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.